We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
- Authors
Freeman, James V; Zhu, Ruo P; Owens, Douglas K; Garber, Alan M; Hutton, David W; Go, Alan S; Wang, Paul J; Turakhia, Mintu P
- Abstract
Warfarin reduces the risk for ischemic stroke in patients with atrial fibrillation (AF) but increases the risk for hemorrhage. Dabigatran is a fixed-dose, oral direct thrombin inhibitor with similar or reduced rates of ischemic stroke and intracranial hemorrhage in patients with AF compared with those of warfarin.
- Publication
Annals of internal medicine, 2011, Vol 154, Issue 1, p1
- ISSN
1539-3704
- Publication type
Journal Article
- DOI
10.7326/0003-4819-154-1-201101040-00289